®
®
This case report demonstrates the successful use of PURINA® PRO PLAN® VETERINARY DIETS Canine EN Gastrointestinal
together with the probiotic supplement FortiFlora® in the dietary management of canine chronic colitis
Benets of Canine EN Gastrointestinal and
FortiFlora
®
in the successful management of
canine chronic colitis
Chronic colitis is frequently diagnosed in veterinary practice and is one
of the most common causes of chronic diarrhoea in dogs. Even though
it is not life threatening, it is nevertheless very uncomfortable for the
patient and inconvenient for the dog’s owners. The term chronic colitis
encompasses several conditions all of which have inammation of the
colon as their predominant pathology. Causes of chronic colitis include
parasitic, infectious, immune-mediated or primary in ammatory
conditions. Regardless of aetiology, the clinical signs of chronic colitis
are similar and easy to recognise - an increased frequency of defaecation
(which is often associated with tenesmus) and poorly formed stools,
often containing mucus and fresh blood. Treatment options for patients
with colitis include standard supportive treatments to restore uid
balance, antibiotics, anti-diarrhoeal or antispasmodic medications during
acute episodes, non-steroidal antiinammatories such as Salazopyrin®,
(sulphasalazine) and corticosteroids
1
. Dietary change is also highly
recommended to provide adequate dietary bre and high digestibility
to limit the passage of ingesta into the colon. Probiotics are also often
recommended on account of their immunomodulatory effect and positive
inuence on intestinal micro oral balance and stability.
Case history
Brygton, a 4-year-old entire male Husky was referred for a nutrition
consultation at the Nantes National Veterinary College. Brygton had
been having episodes of chronic diarrhoea since he was acquired (3,5
years ago). He was otherwise well. The owners reported that the dog’s
stools varied on a daily basis from liquid to soft to barely formed, (faecal
score of 4 to 7 on a 7-point scale- where 7 is very liquid diarrhoea).
Brygton was fed on a mixed diet formulated by his owner including
easily digestible dry food, rice or pasta, accompanied by ham or red
meat to encourage him to eat following many refusals. He was up-to-
date with routine worming and vaccinations. Brygton had received
many previous treatments for his colitis including intestinal mucosal
protectants, corticosteroids, antibiotics (metronidazole) and sulphasalazine
(Salazopyrin
®
- the locally acting colonic anti-inammatory drug) without
much improvement.
Clinical examination
Clinical examination revealed no signi cant abnormalities with the
patient appearing to be in a good general state of health. Brygton
weighed 21 kg and was in ideal body condition (body condition score
5/9).Circulating trypsin-likeimmunoreactivity (TLI), folate, vitamin B12,
albumin and bile acid levels were measured and a faecal examination
was performed. An abdominal ultrasound was also carried out. The only
signicant nding was elevated serum folate (18.6 mg/l, while normal
values should be < 12 μg/L), consistent with small intestinal bacterial
proliferation
2,3
.
Treatment
A dietary treatment protocol based on probiotics and highly digestible
food was recommended. Canine EN Gastrointestinal dry food and a daily
sachet of Canine FortiFlora® were prescribed. It was also recommended
that the food be split into 3 meals per day. After starting this dietary regime,
Brygton’s stools became well-formed with a consistent faecal score of 3/7.
He has now remained on this treatment protocol for four months.
Clinical Case: Canine FortiFlora®/EN Gastrointestinal
Dr Caroline Daumas
DVM, Former nutrition resident at ONIRIS
(Nantes National Veterinary College, France)
®
®
Follow-up
After only one month on Canine EN Gastrointestinal and FortiFlora
®
,
Brygton did not suffer any more bouts of diarrhoea and had gained
weight (+1 kg). Four months later, the owners conrmed no recurrence
of diarrhoea, a good stool quality and maintenance of weight.
About the diet
Nutritional recommendations for the management of canine colitis
include provision of a highly digestible diet to reduce colonic irritation
as a result of poorly digested residues entering the large intestine and
the provision of adequate dietary bre to inuence colonic motility as
well as enhancing luminal SCFA (short chain fatty acid) production.
Canine EN Gastrointestinal is a highly digestible, low residue clinical
diet containing a balance of soluble and insoluble bres and medium
chain fatty acids which are easily absorbed by the small intestine, even
during inammatory processes. It also contains a source of prebiotics
(puried inulin) which helps promote good intestinal health.
Given together with dietary live probiotics, such as FortiFlora
®
(containing
a specic strain of microencapsulated SF68), the two dietary treatments
combined helped ensure a quick return to good colonic health in this
case.
Probiotics are able to both modify the intestinal microora and
enhance the innate immune responses. They are able to:
inuence the composition of the intestinal ora when they are present
in sufcient quantities (more than 1x 10
8
CFU/g) and to promote the
growth of ‘good’ bacteria.
modify the mucus layer in the intestines strengthening the integrity
of the intestinal barrier.
stimulate the synthesis of bactericidal substances (such as defensins)
by the mucosal cells, contributing to the ght against pathogens.
The main indications for probiotics include
4
:
Acute or chronic diarrhoea - because they inhibit the growth of
pathogenic bacteria such as coliforms or salmonellae
Chronic inammatory conditions of the intestines - on account of
their immunomodulatory action
Food allergies or vaccination - due to their ability to help strengthen
the immune barrier
5
.
In chronic colitis, probiotics help optimise the balance of the intestinal
bacterial ora and also have a local immunomodulatory and anti-
inammatory action. It is important to choose probiotics which are
appropriate to the species concerned, ensuring a large quantity of living
microorganisms reach the area to be treated
6
. In the case presented
here, the probiotic supplement (FortiFlora®) sprinkled on the food was
well accepted because it is highly palatable. In chronic conditions, long-
term treatment is recommended to sustain benecial adaptations of
the intestinal microora. FortiFlora® probiotics are both safe and locally
efcacious.
The prognosis for chronic colitis is generally good as long as systemic
health is unaffected. However, elimination of bouts of diarrhoea should
be sought in order to restore the dog’s digestive well-being and improve
quality of life for both dog and owner. In the long term, chronic colonic
diarrhoea can lead to electrolyte imbalance and prevent absorption of
vitamins synthesised by resident bacteria. In cases of proven bacterial
proliferation or recurrent chronic colitis despite conventional treatment,
the use of probiotics is strongly recommended. Whilst the mainstay of
therapy for chronic colitis remains the use of a highly digestible diet
rich in bre, probiotics should now also become an important part of
a practitioner’s therapeutic arsenal to manage this common condition.
Further Reading
1. German A.J., Halladay L.J. and Noble P-J.M. First-choice therapy for
dogs presenting with diarrhea in clinical practice, Veterinary Record,
2010, 167, 810-814.
2. Lecoindre P.; Gaschen F. and Monnet E. Gastroentérologie du chien
et du chat ; collection Atlas ; Les éditions du Point Vétérinaire 2010 ;
p282.
3. Dlvya J.B., Varsha K.K., and Nampoothriri K.M. Newly isolated lactic
acid bacteria with probiotic features for potential application in
food industry, Appl Biochem Biotechnol, 2012, 167: 1314-1324.
4. Wynn S.G., Probiotics in veterinary practice, JAVMA, 2009, 234 (5),
606-613.
5. Benyacoub J., Czarnecki-Maulden G.L., Cavadini C., Sauthier T.,
Anderson R.E., Schrif n E.J. and Von der Weid T. Supplementation of
food with Enterococcus Faecium (SF 68) stimulates immune
functions in young dogs. The Journal of Nutrition. 2003, 133,
1158- 1162.
6. Weese J.S. Microbiologic evaluation of commercial probiotics,
JAVMA, 2002, 220, 794-797.
Nestlé PURINA would like to thank Dr Caroline Daumas
for providing the details of this case. www.purinavets.eu
05C-04/13